YOLFTbeta
41

Genetics Generation Advancement Corp.

4160 · TWO · Healthcare / Diagnostics & Research

36.50TWD+0.95 (+2.67%)

Price History

Full chart

Market Stats

Previous Close35.55
Open36.90
Day Range34.75 – 37.30
52-Week Range36.73 – 55.93
Volume14.79K
Market Cap1.09B
P/E (TTM)61.59
Forward P/E0.00
EPS0.63
Dividend Yield4.54%
Beta0.33
50-Day Avg38.34
200-Day Avg42.10

About

Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services. It also provides AI and data applications, such as bioinformatic, materials sciences, research and development management, enterprise quality management, process production operation, e-submission, tech record, biological simulation, and einfotree_excel products. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOQing Yuan Kang
  • Employees0
  • HeadquartersNo. 28, Xinhu 1st Road, Taipei, Taiwan, 11494, Taiwan
  • Websitehttps://www.gga.asia

Leadership

  • Qing Yuan KangGeneral Manager
  • Yu Chun LiuChief Financial Officer and Executive Vice President
  • Yuchun XiaoAccounting Supervisor
  • John ChangChief Technical Officer

Financials

Income Statement

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue519.51M547.81M592.50M661.86M603.11M
Growth (%)-+5.45%+8.16%+11.71%-8.88%
Cost of Revenue324.02M321.37M355.67M381.84M352.67M
Gross Profit195.49M226.44M236.83M280.01M250.44M
Gross Margin37.63%41.33%39.97%42.31%41.52%
Operating Expense200.00M205.57M218.93M230.48M237.64M
Operating Income-4.51M20.86M17.90M49.53M12.80M
Operating Margin-0.87%3.81%3.02%7.48%2.12%
EBITDA-44.01M50.60M85.95M53.45M
EBITDA Margin-8.03%8.54%12.99%8.86%
Net Income7.84M25.73M28.57M54.70M21.37M
Net Income Margin1.51%4.70%4.82%8.26%3.54%
R&D51.00M52.32M54.47M63.59M62.88M
R&D as % of Total Revenue9.82%9.55%9.19%9.61%10.43%
Interest Expense39.00K106.00K418.00K522.00K639.00K
Interest Expense % of Total Revenue0.01%0.02%0.07%0.08%0.11%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets424.76M455.66M595.05M724.30M806.05M
Total Liabilities106.06M108.20M164.91M170.81M204.05M
Total Equity318.92M347.46M429.94M553.13M601.55M
Cash85.28M57.45M128.48M129.00M65.67M
Net Debt----5.22M

Cash Flow

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.32M51.81M66.86M81.62M-18.33M
Capital Expenditure10.43M8.14M5.12M26.01M31.31M
Free Cash Flow-3.11M43.67M61.74M55.61M-49.64M
Dividends Paid-7.05M11.58M12.85M49.31M
FCF to OCF-42.41%84.28%92.35%68.13%270.78%
Dividend Paid to FCF-16.16%18.75%23.12%-99.33%

Earnings

Report DateOct 31, 2012Mar 22, 2013
EPS Estimate0.010.01
EPS Actual-0.00-0.13
Surprise-119.00%-1400.00%
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.09B
Enterprise Value919.27M
Trailing P/E61.59
Forward P/E0.00
Price / Sales1.77
Price / Book2.26
EPS0.63
Book Value17.60
Revenue (TTM)614.42M
Gross Profit (TTM)253.79M
EBITDA19.04M
Profit Margin2.92%
Operating Margin0.02%
Return on Equity3.74%
Return on Assets0.14%
Shares Outstanding28.01M
Shares Float18.72M
Beta0.33
Dividend Yield4.54%
Dividend Rate1.76
Payout Ratio275.23%

Dividends

20251×
1.76Oct 3, 2025
20241×
0.48Sep 19, 2024
20231×
0.43Sep 14, 2023
20221×
0.25Sep 5, 2022
20201×
0.59Aug 4, 2020
20191×
0.54Aug 5, 2019
20181×
0.35Aug 2, 2018

Stock Splits

  • Sep 9, 20261049.5835:1000
  • Sep 19, 20241050.5968:1000
  • Sep 14, 20231047.7548:1000
  • Aug 27, 20121.035:1